These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7542335)

  • 1. Substance P stimulates and inhibits intestinal peristalsis via distinct receptors.
    Holzer P; Schluet W; Maggi CA
    J Pharmacol Exp Ther; 1995 Jul; 274(1):322-8. PubMed ID: 7542335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea.
    Figini M; Emanueli C; Bertrand C; Sicuteri R; Regoli D; Geppetti P
    Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase distention-induced peristalsis through activation of neurokinin-1 receptors on smooth muscle and interstitial cells of cajal.
    Nieuwmeyer F; Ye J; Huizinga JD
    J Pharmacol Exp Ther; 2006 Apr; 317(1):439-45. PubMed ID: 16330493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
    Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.
    Liu L; Shang F; Markus I; Burcher E
    J Pharmacol Exp Ther; 2002 Aug; 302(2):627-35. PubMed ID: 12130725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitory modulation of guinea-pig intestinal peristalsis caused by capsaicin involves calcitonin gene-related peptide and nitric oxide.
    Bartho L; Holzer P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):102-9. PubMed ID: 8750923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
    Pedersen KE; Buckner CK; Meeker SN; Undem BJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
    Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
    Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
    Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
    Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
    Lördal M; Bränström R; Hellström PM
    Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization with a selective agonist discriminates between multiple tachykinin receptors.
    Laufer R; Gilon C; Chorev M; Selinger Z
    J Pharmacol Exp Ther; 1988 May; 245(2):639-43. PubMed ID: 2835478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of MEN 11467: a potent new selective and orally- effective peptidomimetic tachykinin NK(1) receptor antagonist.
    Cirillo R; Astolfi M; Conte B; Lopez G; Parlani M; Sacco G; Terracciano R; Fincham CI; Sisto A; Evangelista S; Maggi CA; Manzini S
    Neuropeptides; 2001; 35(3-4):137-47. PubMed ID: 11884203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised.
    Sanger GJ; Tuladhar BR; Brown J; Aziz E; Sivakumar D; Furness JB
    Auton Autacoid Pharmacol; 2007 Apr; 27(2):105-11. PubMed ID: 17391280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in circular muscle contraction and peristaltic motor inhibition caused by tachykinin NK1 receptor agonists in the guinea-pig small intestine.
    Shahbazian A; Holzer P
    Neurogastroenterol Motil; 2000 Apr; 12(2):197-204. PubMed ID: 10877607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachykinin NK(1)receptor-mediated inhibitory responses in the guinea-pig small intestine.
    Lecci A; De Giorgio R; Barthó L; Sternini C; Tramontana M; Corinaldesi R; Giuliani S; Maggi CA
    Neuropeptides; 1999 Feb; 33(1):91-7. PubMed ID: 10657476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic role of muscarinic acetylcholine and tachykinin NK-2 receptors in intestinal peristalsis.
    Holzer P; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):194-201. PubMed ID: 8170503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat.
    Krowicki ZK; Hornby PJ
    J Pharmacol Exp Ther; 2000 Apr; 293(1):214-21. PubMed ID: 10734172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
    Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
    Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.